Steroid administration in heart and heart-lung transplantation: Is the timing adequate?

Annals of Thoracic Surgery

Volumn 61, Issue 2, 1996, Pages 674-678

  Wan, Song ^a   DeSmet, Jean Marie ^a   Antoine, Martine ^a   Goldman, Michel ^a   Vincent, Jean Louis ^a   LeClerc, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORBIDITY; PRIORITY JOURNAL;

EID: 0030059707     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)01059-9     Document Type: Article

References (33)

1. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The registry of the international society for heart and lung transplantation: eleventh official report - 1994. J Heart Lung Transplant 1994; 13:561-70.
2. Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988; 11:917-24.
3. Kobashigawa JA, Kirklin JK, Naftel DC, et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993;12:355-66.
4. Ibrahim M, Masters RG, Hendry PJ, et al. Determinants of hospital survival after cardiac transplantation. Ann Thorac Surg 1995;59:604-8.
5. Pflugfelder PW, Thomson D, Singh NR, Menkis AH, McKenzie FN, Kostuk WJ. Cardiac allograft ischemic time: relation to graft survival and cardiac function. Circulation 1989;80(Suppl 3):116-21.
6. Primo G, LeClerc JL, Antoine M, DeSmet JM, Joris M. A survey of nine years heart transplantation at Erasme Hospital, University of Brussels. Acta Cardiol 1991;46:555-65.
7. Fullerton DA, Campbell DN, Jones SD, et al. Heart transplantation in childen and young adults: early and intermediate-term results. Ann Thorac Surg 1995;59:804-12.
8. Bouchart F, Gundry SR, van Schaack-Gonzales, et al. Methotrexate as rescue/adjunctive immunotherapy in infant and adult heart transplantation. J Heart Lung Transplant 1993; 12:427-33.
9. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993;1:3-27.
10. Azuma H, Heemann UW, Tullius SG, Tilney NL. Cytokines and adhesion molecules in chronic rejection. Clin Transplantation 1994;8:168-80.
11. Fyfe A, Daly P, Galligan L, Pirc L, Feindel C, Cardella C. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and Interleukin-4 production within the graft. J Am Coll Cardiol 1993;21:171-6.
12. Jordan SC, Czer L, Toyoda M, et al. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. J Heart Lung Transplant 1993;12:333-7.
13. Yoshida Y, Iwaki Y, Pham S, et al. Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. Ann Thorac Surg 1993;55:89-93.
14. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft: a sequential study. Transplantation 1994;57:1333-7.
15. Wan S, Marchant A, DeSmet JM, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg (in press).
16. Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 1979;76:262-8.
17. Jansen NJG, van Oeveren W, v.d. Broek L, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:515-25.
18. Jorens PG, de Jongh R, de Backer W, et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass: the influence of pretreatment with methylprednisolone. Am Rev Respir Dis 1993;148:890-5.
19. Tabardel Y, Duchateau J, Schmartz D, et al. Corticosteroids increase blood interleukin 10 levels during cardiopulmonary bypass in men. Surgery (In press).
20. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the TH1/TH2 paradigm in transplantation. Curr Opin Immunol 1994;6:757-64.
21. Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart. Surg Forum 1960;11:18-9.
22. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 1995;60:801-4.
23. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
24. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11: 165-90.
25. Van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994;180:1985-8.
26. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-6.
27. Kawauchi M, Gundry SR, de Begona JA, et al. Prolonged preservation of human pediatric hearts for transplantation: correlation of ischemic time and subsequent function. J Heart Lung Transplant 1993;12:55-8.
28. Francalancia NA, Aeba R, Yousem SA, Griffith BP, Marrone GC. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. J Heart Lung Transplant 1994;13:498-507.
29. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
30. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993;40:1016-21.
31. Oz MC, Naka Y, Liao H, et al. Coronary sinus interleukin-8 and myoglobin are elevated following human heart transplantation [Abstract]. Circulation 1994;90(Suppl 1):361.
32. Land W. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation. Transplant Proc 1994;26:3169-71.
33. Kutukculer N, Clark K, Rigg KM, et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995;59:333-40.